Genetic analysis of the merozoite surface protein-1 block 2 allelic types in Plasmodium falciparum clinical isolates from Lao PDR.

Naly Khaminsou, Onanong Kritpetcharat, Jureerut Daduang, Lertchai Charerntanyarak, Panutas Kritpetcharat
Author Information
  1. Naly Khaminsou: Faculty of Medical Technology, University of Health Science, Vientiane, Lao PDR.

Abstract

BACKGROUND: MSP-1 is one of the potential malarial vaccine candidate antigens. However, extensive genetic polymorphism of this antigen in the field isolates of Plasmodium falciparum represents a major hindrance for the development of an effective vaccine. Therefore, this study aimed to establish the prevalence and genetic polymorphisms of K1, MAD20 and RO33 allelic types of msp-1 block 2 among P. falciparum clinical isolates from Lao PDR.
METHODS: Plasmodium falciparum isolates were collected from 230 P. falciparum-infected blood samples from three regions of Lao PDR. K1, MAD20 and RO33 were detected by nested PCR; SSCP was used for polymorphism screening. The nested PCR products of each K1, MAD20 and RO33 allelic types that had different banding patterns by SSCP, were sequenced.
RESULTS: The overall prevalence of K1, MAD20 and RO33 allelic types in P. falciparum isolates from Lao PDR were 66.95%, 46.52% and 31.30%, respectively, of samples under study. Single infections with K1, MAD20 and RO33 allelic types were 27.83%, 11.74% and 5.22%, respectively; the remainders were multiple clonal infections. Neither parasite density nor age was related to MOI. Sequence analysis revealed that there were 11 different types of K1, eight different types of MAD20, and 7 different types of RO33. Most of them were regional specific, except type 1 of each allelic type was common found in 3 regions under study.
CONCLUSIONS: Genetic polymorphism with diverse allele types was identified in msp-1 block 2 among P. falciparum clinical isolates in Lao PDR. A rather high level of multiple clonal infections was also observed but the multiplicity of infection was rather low as not exceed 2.0. This basic data are useful for treatment and malaria control program in Lao PDR.

References

  1. Trans R Soc Trop Med Hyg. 2005 Nov;99(11):833-9 [PMID: 16112154]
  2. Trans R Soc Trop Med Hyg. 1999 Feb;93 Suppl 1:59-64 [PMID: 10450428]
  3. Trans R Soc Trop Med Hyg. 1996 Nov-Dec;90(6):704-11 [PMID: 9015525]
  4. Malar J. 2010 May 17;9:131 [PMID: 20478015]
  5. Mem Inst Oswaldo Cruz. 1998 Sep-Oct;93(5):631-8 [PMID: 9830530]
  6. Am J Trop Med Hyg. 1998 Nov;59(5):726-35 [PMID: 9840589]
  7. Nat Med. 2000 Jun;6(6):689-92 [PMID: 10835687]
  8. Mol Biochem Parasitol. 2002 Nov-Dec;125(1-2):163-71 [PMID: 12467983]
  9. Malar J. 2010 Feb 24;9:59 [PMID: 20181273]
  10. Trans R Soc Trop Med Hyg. 1999 Feb;93 Suppl 1:21-8 [PMID: 10450422]
  11. Mol Microbiol. 2004 Apr;52(1):159-68 [PMID: 15049818]
  12. Am J Trop Med Hyg. 1996 Jun;54(6):632-43 [PMID: 8686784]
  13. Parasitol Today. 1994 May;10(5):182-4 [PMID: 15275468]
  14. Malar J. 2008 Jan 23;7:17 [PMID: 18215251]
  15. Infect Genet Evol. 2006 Sep;6(5):417-24 [PMID: 16517218]
  16. Infect Immun. 2006 Feb;74(2):1313-22 [PMID: 16428781]
  17. Southeast Asian J Trop Med Public Health. 2004 Sep;35(3):547-51 [PMID: 15689064]
  18. J Infect Dis. 2001 Mar 1;183(5):796-804 [PMID: 11181157]
  19. Parasitol Int. 2008 Jun;57(2):143-9 [PMID: 18160336]
  20. Am J Trop Med Hyg. 2004 Jan;70(1):20-6 [PMID: 14971693]
  21. Malar J. 2011 Sep 22;10:276 [PMID: 21936949]
  22. Mol Biol Evol. 2011 Oct;28(10):2731-9 [PMID: 21546353]
  23. Malar J. 2009 Jun 20;8:135 [PMID: 19545390]
  24. J Infect Dis. 1999 Apr;179(4):989-95 [PMID: 10068596]
  25. Acta Trop. 2002 Nov;84(2):83-92 [PMID: 12429425]
  26. Am J Trop Med Hyg. 2005 Mar;72(3):249-51 [PMID: 15772315]
  27. Vaccine. 2009 Mar 4;27(10):1651-60 [PMID: 19038302]
  28. Malar J. 2007 May 21;6:60 [PMID: 17517129]
  29. Vaccine. 2003 Dec 8;22(1):30-41 [PMID: 14604568]
  30. Electrophoresis. 2001 Jun;22(10):1925-9 [PMID: 11465490]
  31. J Infect Dis. 2002 Mar 15;185(6):820-7 [PMID: 11920300]
  32. Mol Biochem Parasitol. 1993 Apr;58(2):283-92 [PMID: 8479452]
  33. Mol Biochem Parasitol. 1993 May;59(1):1-14 [PMID: 8515771]
  34. Malar J. 2003 May 9;2:12 [PMID: 12773207]
  35. Parassitologia. 1999 Sep;41(1-3):409-14 [PMID: 10697894]
  36. Gene. 2003 Jan 30;304:65-75 [PMID: 12568716]

MeSH Term

Adolescent
Adult
Aged
Alleles
Base Sequence
Child
Child, Preschool
DNA, Protozoan
Evolution, Molecular
Female
Humans
Infant
Laos
Malaria, Falciparum
Male
Merozoite Surface Protein 1
Middle Aged
Molecular Sequence Data
Parasitemia
Phylogeny
Plasmodium falciparum
Polymorphism, Genetic
Prevalence
Sequence Analysis, DNA
Young Adult

Chemicals

DNA, Protozoan
Merozoite Surface Protein 1

Word Cloud

Created with Highcharts 10.0.0typesisolatesfalciparumK1MAD20RO33allelicLaoPDR2PdifferentpolymorphismPlasmodiumstudyblockclinicalinfectionsvaccinegeneticprevalencemsp-1amongsamplesregionsnestedPCRSSCPrespectively11multipleclonalanalysistypeGeneticratherBACKGROUND:MSP-1onepotentialmalarialcandidateantigensHoweverextensiveantigenfieldrepresentsmajorhindrancedevelopmenteffectiveThereforeaimedestablishpolymorphismsMETHODS:collected230falciparum-infectedbloodthreedetectedusedscreeningproductsbandingpatternssequencedRESULTS:overall6695%4652%3130%Single2783%74%522%remaindersNeitherparasitedensityagerelatedMOISequencerevealedeight7regionalspecificexcept1commonfound3CONCLUSIONS:diversealleleidentifiedhighlevelalsoobservedmultiplicityinfectionlowexceed0basicdatausefultreatmentmalariacontrolprogrammerozoitesurfaceprotein-1

Similar Articles

Cited By